Paul A. Friedman, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 86,170 shares at $350.19 ($30.6M) on 2025-08-11, disclosed to the SEC on 2025-08-13.
Scheduled sale ($30.6M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $350.19 | 2,903 | $1.0M | 3.3% |
| 2 | $350.19 | 2,903 | $1.0M | 3.3% |
| 3 | $351.04 | 300 | $105K | 0.3% |
| 4 | $350.93 | 3,303 | $1.2M | 3.8% |
| 5 | $350.93 | 3,303 | $1.2M | 3.8% |
| 6 | $351.59 | 3,202 |
| $1.1M |
| 3.7% |
| 7 | $351.59 | 3,202 | $1.1M | 3.7% |
| 8 | $352.61 | 1,382 | $487K | 1.6% |
| 9 | $352.61 | 1,382 | $487K | 1.6% |
| 10 | $354.06 | 4,768 | $1.7M | 5.5% |
| 11 | $354.06 | 4,768 | $1.7M | 5.5% |
| 12 | $355.00 | 6,546 | $2.3M | 7.6% |
| 13 | $355.97 | 5,244 | $1.9M | 6.1% |
| 14 | $355.97 | 5,244 | $1.9M | 6.1% |
| 15 | $356.94 | 5,094 | $1.8M | 5.9% |
| 16 | $356.94 | 5,094 | $1.8M | 5.9% |
| 17 | $357.93 | 8,434 | $3.0M | 9.9% |
| 18 | $357.93 | 8,434 | $3.0M | 9.9% |
| 19 | $358.83 | 5,032 | $1.8M | 5.9% |
| 20 | $358.83 | 5,032 | $1.8M | 5.9% |
| 21 | $359.81 | 600 | $216K | 0.7% |
| Total | $355.32 avg | 86,170 | $30.6M | 100% |
| Filing → |
| MDGL | SELL | 2025-12-12 | $26.5M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $95.1M | — | Filing → |
| MDGL | SELL | 2025-07-22 | $980K | — | Filing → |